USANA Health Sciences, Inc. (NYSE:USNA) CEO Jim Brown Sells 5,000 Shares

USANA Health Sciences, Inc. (NYSE:USNA) CEO Jim Brown sold 5,000 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $29.47, for a total value of $147,350.00. Following the completion of the sale, the chief executive officer now directly owns 15,716 shares of the company’s stock, valued at $463,150.52. The trade was a 24.14 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

USANA Health Sciences Trading Up 1.3 %

Shares of USANA Health Sciences stock opened at $29.97 on Tuesday. The firm has a market capitalization of $571.21 million, a P/E ratio of 10.59, a P/E/G ratio of 0.93 and a beta of 0.87. The business has a fifty day simple moving average of $33.42 and a two-hundred day simple moving average of $36.47. USANA Health Sciences, Inc. has a 12 month low of $27.71 and a 12 month high of $50.32.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.49 by $0.15. The business had revenue of $213.61 million during the quarter, compared to analyst estimates of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. Analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Hedge Funds Weigh In On USANA Health Sciences

Several institutional investors and hedge funds have recently added to or reduced their stakes in USNA. Pacer Advisors Inc. lifted its position in USANA Health Sciences by 16.5% during the third quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock valued at $20,638,000 after buying an additional 76,904 shares during the period. Pzena Investment Management LLC increased its holdings in shares of USANA Health Sciences by 7.5% during the third quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock valued at $39,801,000 after acquiring an additional 72,977 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of USANA Health Sciences by 7.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock valued at $27,751,000 after acquiring an additional 55,059 shares in the last quarter. Jane Street Group LLC increased its holdings in shares of USANA Health Sciences by 330.0% during the fourth quarter. Jane Street Group LLC now owns 39,979 shares of the company’s stock valued at $1,435,000 after acquiring an additional 30,681 shares in the last quarter. Finally, Norges Bank bought a new position in shares of USANA Health Sciences during the fourth quarter valued at $953,000. Hedge funds and other institutional investors own 54.25% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on USNA. StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. Sidoti lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th. Finally, DA Davidson dropped their price target on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a research note on Thursday, February 27th.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.